-+ 0.00%
-+ 0.00%
-+ 0.00%

A subsidiary of Tianjin Pharmaceutical (600488.SH) obtained a drug registration certificate for compound electrolyte injections

Zhitongcaijing·08/03/2026 07:49:04
Listen to the news

Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for compound electrolyte injections approved and issued by the State Drug Administration. This drug can be used as a supplementary source of water, electrolytes, and an alkalizing agent. Obtaining a drug registration certificate this time has improved the company's formulation product range, which will have a certain positive impact on the company's expansion of the domestic formulation market and improvement of the company's performance.